United States · FDA National Drug Code directory

Lisinopril and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 51655-412_49ec4849-0989-39b2-e063-6294a90a3d7b
Product NDC: 51655-412
Form: TABLET
Composition / generic term: Lisinopril and Hydrochlorothiazide
Labeler: Northwind Health Company, LLC
Marketing category: ANDA
Marketing start / end (source format): 20140729
Source listing expiry: 20271231

Source-listed ingredients

HYDROCHLOROTHIAZIDE — 12.5 mg/1
LISINOPRIL — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

90 TABLET in 1 BOTTLE, PLASTIC (51655-412-26) · 51655-412-26
30 TABLET in 1 BOTTLE, DISPENSING (51655-412-30) · 51655-412-30
100 TABLET in 1 BOTTLE, PLASTIC (51655-412-60) · 51655-412-60

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →